[1]
N. Reina-Llompart, S. Serrano-López, G. Torres-Iglesias, and J. Álvarez-Troncoso, “Tofacitinib improves motor symptoms in parkinsonism associated with a heterozygous NGLY1 variant and autoimmune disease”, EJCRIM, vol. 12, no. 11, Oct. 2025, doi: 10.12890/2025_005886.